News | January 04, 2023
Themis Medicare launches Lenzetto for treatment of menopausal symptoms
It ensures sufficient serum estradiol levels to alleviate menopausal symptoms
It ensures sufficient serum estradiol levels to alleviate menopausal symptoms
To create leading company developing medicines targeting metalloenzymes
Kyfora Bio will focus on the synthesis of cationic polymers, lipids, and other materials used in nucleic acid delivery for cell and gene therapies.
Greenko ZeroC will supply Carbon Free Energy and enable Green Hydrogen along with its various chemical derivatives.
The company is one of the most profitable companies manufacturing speciality chemicals in India
Quantori develops solutions on the Databricks Lakehouse Platform providing real-time insights
Having a healthy gut is key as it permits the body to build a stronger immune system
Upon approval, XPHOZAH would be the first and only phosphate absorption inhibitor, offering patients a novel mechanism
Tafasitamab is conditionally approved by both the U.S. Food and Drug Administration and European Medicines Agency
All claims against the company in the litigation have now been dismissed.
Subscribe To Our Newsletter & Stay Updated
